Page last updated: 2024-08-16

(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and am 251

(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with am 251 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bisogno, T; Cascio, MG; Di Marzo, V; Ramunno, A; Saturnino, C; Urbani, P1
Brogi, S; Corelli, F; Di Marzo, V; Ligresti, A; Mugnaini, C; Pasquini, S; Tafi, A1
Decara, J; Elguero, J; Fresno, N; Girón, R; Goya, P; Macías-González, M; Martín, MI; Pérez-Fernández, R; Rodríguez de Fonseca, F; Rodríguez-Álvarez, A1
Campillo, NE; de Ceballos, ML; Girón, R; González-Naranjo, P; Martín-Fontelles, MI; Martin-Requero, A; Páez, JA; Pérez, C; Pérez-Macias, N; Roca, C; Sánchez-Robles, E; Vaca, G1
Campillo, NE; Carrillo-López, N; Girón, R; González-Naranjo, P; Martín-Fontelles, MI; Martín-Vírgala, J; Naves, M; Páez, JA; Pérez, C; Sánchez-Robles, EM1

Other Studies

5 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and am 251

ArticleYear
Novel sterically hindered cannabinoid CB1 receptor ligands.
    Bioorganic & medicinal chemistry, 2008, Aug-01, Volume: 16, Issue:15

    Topics: Acetamides; Animals; Cell Line, Tumor; Ligands; Mice; Molecular Structure; Receptor, Cannabinoid, CB1; Structure-Activity Relationship

2008
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Stereoisomerism

2011
Discovery of Potent Dual PPARα Agonists/CB1 Ligands.
    ACS medicinal chemistry letters, 2011, Nov-10, Volume: 2, Issue:11

    Topics:

2011
Indazolylketones as new multitarget cannabinoid drugs.
    European journal of medicinal chemistry, 2019, Mar-15, Volume: 166

    Topics: Aspartic Acid Endopeptidases; Butyrylcholinesterase; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Drug Design; Humans; Indazoles; Ketones; Neurons; Receptor, Cannabinoid, CB2

2019
New cannabinoid receptor antagonists as pharmacological tool.
    Bioorganic & medicinal chemistry, 2020, 10-01, Volume: 28, Issue:19

    Topics: 3T3 Cells; Animals; Cannabinoid Receptor Antagonists; Cannabinoids; Dose-Response Relationship, Drug; Ethers; Indazoles; Mice; Molecular Structure; Receptors, Cannabinoid; Structure-Activity Relationship

2020